| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 18, 2002
From the Vascular Gene Therapy Unit, University of Manchester (P.A.K., A.D., C.E.A., T.V., M.G.C., P.R.L.), and Department of Medicine, Manchester Royal Infirmary (S.S., A.M.H.), Manchester, UK. Drs Castro and Lowenstein are now with the Gene Therapeutics Research Institute, Cedars Sinai Medical Center, Los Angeles, Calif. * To whom correspondence should be addressed. E-mail: paul.a.kingston{at}man.ac.uk.
Background--Extracellular matrix (ECM) remodeling is central to the development of restenosis after PTCA. Substantial evidence implicates transforming growth factor- Methods and Results--Porcine coronary arteries received an adenovirus expressing TGF- Conclusions--Expression of TGF-
Revised on June 23, 2003
Accepted on August 1, 2003
Adenovirus-Mediated Gene Transfer of Transforming Growth Factor-
Paul A. Kingston MRCP, PhD*,
3, but Not Transforming Growth Factor-
1, Inhibits Constrictive Remodeling and Reduces Luminal Loss After Coronary Angioplasty
1 (TGF-
1), a regulator of ECM deposition by vascular cells, in its pathogenesis. TGF-
3 reduces TGF-
1--induced ECM deposition in cutaneous wounds. We therefore investigated the effects of intracoronary expression of TGF-
3 and TGF-
1 on luminal loss after angioplasty.
3, TGF-
1, or lacZ (
-galactosidase), or PBS only, at the site of angioplasty. Morphometric analysis 28 days after angioplasty confirmed reduced luminal loss in TGF-
3 vessels (-0.65±0.10 mm2) compared with lacZ (-1.18±0.19 mm2) or PBS only (-1.19±0.17 mm2; P=0.003). Luminal loss was not reduced in TGF-
1 vessels (-1.02±0.19 mm2; P=0.48). An increase in the external elastic lamina area in TGF-
3-treated vessels (+0.73±0.32 mm2) contrasted with decreases in control vessels (mean, -0.53±0.17 mm2; P=0.001) and TGF-
1 vessels (-0.87±0.34 mm2; P=0.003). Collagen content increased at the site of injury in TGF-
3-treated vessels (26.1±14.2%) but decreased in the lacZ (-22.8±6.6%) and PBS-only (-23.4±7.0%; P=0.002) groups and was not significantly changed in TGF-
1-treated vessels.
3 inhibits constrictive remodeling after PTCA and reduces luminal loss. This is accompanied by increased adventitial collagen, which may act as an external "scaffold" preventing vessel constriction. These findings confirm the potential of gene therapies that modify ECM remodeling for prophylaxis of restenosis.
This article has been cited by other articles:
![]() |
Z. Jiang, P. Yu, M. Tao, C. Fernandez, C. Ifantides, O. Moloye, G. S. Schultz, C. K. Ozaki, and S. A. Berceli TGF-beta- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H482 - H488. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Khan, A. Agrotis, and A. Bobik Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury Cardiovasc Res, May 1, 2007; 74(2): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.G. Sluijter, R. E. Verloop, W. P.C. Pulskens, E. Velema, J. M. Grimbergen, P. H. Quax, M.-J. Goumans, G. Pasterkamp, and D. P.V. de Kleijn Involvement of furin-like proprotein convertases in the arterial response to injury Cardiovasc Res, October 1, 2005; 68(1): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |